Marshall Wace’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Marshall Wace’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-59,455	Closed	-$1.52M	–	1334
2018 Q2	$1.52M	Buy	+59,455	New	+$1.39M	0.02%	456
2016 Q1	–	Sell	-185,427	Closed	-$6.34M	–	1261
2015 Q4	$6.34M	Buy	+185,427	New	+$5.79M	0.06%	330
2015 Q3	–	Sell	-25,798	Closed	-$1.15M	–	1126
2015 Q2	$1.15M	Sell	25,798 -96,558	-79%	-$3.63M	0.02%	574
2015 Q1	$4.23M	Buy	+122,356	New	+$3.33M	0.06%	349

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Marshall Wace's DPLO Position: Q3 2018 in Review

Marshall Wace sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 59,455 shares — an estimated $1.52M sold.

Marshall Wace first reported a position in DPLO in Q1 2015 and held it in 4 quarters. The position peaked at $6.34M in Q4 2015. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

Marshall Wace reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
Marshall Wace sold 59,455 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $1.52M.
Marshall Wace first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 4 quarters.
Marshall Wace's DIPLOMAT PHARMACY, INC. position peaked at $6.34M in Q4 2015.
178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Marshall Wace's 13F filing for Q3 2018, filed 14 Nov 2018.